Key result
Current smoking cessation resources are rated only ~8% effective by lung cancer patients facing withdrawal barriers.
Why the study?
Although quitting smoking after a cancer diagnosis improves outcomes and quality of life, 30% of patients continue smoking, leaving a gap between evidence and patient perspectives.
Population
40 lung cancer patients who smoke post-diagnosis across two community oncology sites in Connecticut
Design
Cross-sectional survey
Authors
Loading...
Routine proactive cessation support by oncology teams is warranted despite stigma; hypothesis-generating for tailored withdrawal- and stress-focused interventions.
Lung cancer patients who smoke post-diagnosis report low perceived effectiveness of current cessation resources and face significant internal barriers like withdrawal and stress, highlighting the need for proactive, stigma-aware support.
Li et al. (2026) studied this question. Lung cancer patients reported low effectiveness of current smoking cessation resources (7.5%), identifying withdrawal (52.5%) and stress relief (42.5%) as the primary barriers to quitting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: